Current Approaches to Epigenetic Therapy

Area of Science:

• Biomedical Sciences
• Molecular Biology
• Pharmacology

Background:

• Epigenetic therapy is a rapidly advancing field with significant potential for treating diverse diseases.
• Current therapeutic strategies primarily involve small molecules, with some already in clinical use.
• Emerging approaches utilize novel technologies like dCas9 and non-coding RNAs.

Purpose of the Study:

• To provide a comprehensive overview of the current research landscape in epigenetic therapy.
• To discuss the established and emerging methodologies within epigenetic therapy.
• To evaluate the future prospects and inherent limitations of epigenetic therapeutic applications.

Main Methods:

• Review of current scientific literature on epigenetic therapy.
• Analysis of established pharmacological approaches using small molecules.
• Exploration of innovative techniques including dCas9-based gene editing and small non-coding RNAs.

Main Results:

• Small molecule epigenetic drugs represent the most clinically advanced therapeutic strategy.
• dCas9-based systems and small non-coding RNAs are under active investigation for therapeutic potential.
• The field is characterized by diverse approaches with varying stages of development.

Conclusions:

• Epigenetic therapy holds considerable promise for treating a broad spectrum of diseases.
• Further research is essential to overcome limitations and fully realize the potential of various epigenetic strategies.
• The integration of pharmacological and novel molecular approaches may define the future of epigenetic medicine.